RecruitingNCT07007156

Is a Positive NECPAL in ICU Patients Associated With Higher Mortality

Sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Enrollment

199 participants

Start Date

Jun 12, 2025

Study Type

OBSERVATIONAL

Conditions

Acute Disease

Summary

The aim of the present study is to evaluate the usefulness of the NECPAL scale in identifying Intensive Care Unit (ICU)-admitted patients at higher risk of dying within 90 days of ICU admission

Eligibility

Min Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This observational study examines whether a tool called NECPAL — a clinical scale designed to identify patients who may be nearing the end of life — is useful for predicting which elderly ICU patients are most at risk of dying within 90 days of admission. By applying this tool at ICU admission, clinicians hope to better identify patients who might benefit from early palliative care discussions. Adults aged 75 or older who are admitted to the ICU at the participating hospital and survive the first 24 hours of ICU care are eligible. Participation involves the NECPAL assessment at admission and follow-up monitoring of outcomes, with no changes to the medical care provided. This summary was generated by AI to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.